Serum MicroRNA-155 as a Potential Biomarker to Track Disease in Breast Cancer

Abstract

Our results suggest that serum miR-155 is a potential biomarker to discriminate breast cancer patients from healthy subjects. For the first time, we demonstrated a declined trend of miR-155 after surgery and chemotherapy, which raises the possibility to use it as an indicator for treatment response.